Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
29.52
-0.83 (-2.73%)
At close: Aug 20, 2026, 4:00 PM EDT
29.40
-0.12 (-0.41%)
Pre-market: Aug 21, 2026, 8:12 AM EDT

Arcus Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-460-353-283-307-26753
Depreciation & Amortization
101010864
Asset Writedown & Restructuring Costs
--20---
Loss (Gain) From Sale of Investments
-11-13-25-19-5
Stock-Based Compensation
636076736555
Other Operating Activities
1181010113
Change in Accounts Receivable
992815704-17
Change in Accounts Payable
5243-18-5
Change in Unearned Revenue
-106-240-56-68-112-368
Change in Other Net Operating Assets
51347-172314
Operating Cash Flow
-474-482-170-306438-256
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1-2-6-24-6-26
Investment in Securities
6468-78218-40422
Other Investing Activities
-----3-
Investing Cash Flow
6366-84194-413-4

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-4947---
Net Debt Issued (Repaid)
-4947---
Issuance of Common Stock
3134392373323232
Repurchase of Common Stock
---7---
Other Financing Activities
----105
Financing Cash Flow
3134882773333237

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-987223-7958-23

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-475-484-176-330432-282
Free Cash Flow Growth
------
Free Cash Flow Margin
-405.98%-195.95%-68.22%-282.05%385.71%-73.63%
Free Cash Flow Per Share
-3.99-4.51-1.95-4.466.00-3.81
Levered Free Cash Flow
-270.63-162.25-41.25-187.75617.75-644.75
Unlevered Free Cash Flow
-263.75-157.25-38.75-186.5619-644.75

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
771---
Cash Income Tax Paid
---53-
Change in Working Capital
-87-19422-71623-376
SEC Filings: 10-K · 10-Q